Group One Trading
PHXM

Group One Trading’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Group One Trading’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,059
Closed -$7.73K – 8521
2023
Q2 		$7.73K Hold
1,059
– – ﹤0.01% 6518
2023
Q1 		$10.4K Hold
1,059
– – ﹤0.01% 5911
2022
Q4 		$3.5K Hold
1,059
– – ﹤0.01% 6483
2022
Q3 		$6K Hold
1,059
– – ﹤0.01% 6793
2022
Q2 		$12K Buy
1,059
+17
+2% +$210 ﹤0.01% 6678
2022
Q1 		$19K Sell
1,042
-20
-2% -$378 ﹤0.01% 6795
2021
Q4 		$25K Buy
1,062
+862
+431% +$29.1K ﹤0.01% 6850
2021
Q3 		$12K Buy
+200
New +$11.2K ﹤0.01% 7436

Other funds holding PHXM

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's PHXM Position: Q3 2023 in Review

Group One Trading sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2023, closing a stake of 1,059 shares — an estimated $7.73K sold.

Group One Trading first reported a position in PHXM in Q3 2021 and held it in 8 quarters. The position peaked at $25K in Q4 2021. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2023.

  • Group One Trading reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 1,059 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2023, an estimated $7.73K.
  • Group One Trading first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2021 and held it in 8 quarters.
  • Group One Trading's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $25K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.